Skip to Content

Notice

Manufacturer of Controlled Substances; Notice of Registration; Chattem Chemicals, Inc.

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

By Notice dated June 18, 2012, and published in the Federal Register on June 26, 2012, 77 FR 38086, Chattem Chemicals, Inc., 3801 St. Elmo Avenue, Building 18, Chattanooga, Tennessee 37409, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances:

DrugSchedule
Gamma Hydroxybutyric Acid (2010)I
4-Methoxyamphetamine (7411)I
Dihydromorphine (9145)I
Amphetamine (1100)II
Methamphetamine (1105)II
Lisdexamfetamine (1205)II
Methylphenidate (1724)II
Pentobarbital (2270)II
Codeine (9050)II
Dihydrocodeine (9120)II
Oxycodone (9143)II
Hydromorphone (9150)II
Hydrocodone (9193)II
Meperidine (9230)II
Methadone (9250)II
Methadone intermediate (9254)II
Morphine (9300)II
Oripavine (9330)II
Thebaine (9333)II
Opium tincture (9630)II
Opium, powdered (9639)II
Opium, granulated (9640)II
Oxymorphone (9652)II
Noroxymorphone (9668)II
Alfentanil (9737)II
Remifentanil (9739)II
Sufentanil (9740)II
Tapentadol (9780)II
Fentanyl (9801)II

The company plans to manufacture the listed controlled substances in bulk for distribution and sale to its customers. Regarding (9640) the company plans to manufacture another controlled substance for sale to its customers.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Chattem Chemicals, Inc., to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Chattem Chemicals, Inc., to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed.

Dated: October 9, 2012.

Joseph T. Rannazzisi,

Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. 2012-25637 Filed 10-17-12; 8:45 am]

BILLING CODE 4410-09-P